Table 2.
Generalised linear model for total cholesterol.
| Coefficient | Robust standard error |
P | 95% confidence interval |
||
|---|---|---|---|---|---|
| Lower | Upper | ||||
| Follow-up versus baseline | −0.079 | 0.179 | 0.658 | −0.430 | 0.271 |
| ART experienced versus ART naïve | 1.436 | 0.321 | <0.001 | 0.807 | 2.065 |
| Interaction between time and ART | −0.645 | 0.200 | 0.001 | −1.036 | −0.253 |
| Males versus females | 0.094 | 0.157 | 0.550 | −0.214 | 0.401 |
| Age (years) | 0.028 | 0.007 | <0.001 | 0.015 | 0.042 |
| Body mass index at baseline | 0.023 | 0.012 | 0.062 | −0.001 | 2.028 |
| Constant | 1.839 | ||||
Note: standard error adjusted for 215 clusters in study ID at baseline; ART: antiretroviral therapy, significant P < 0.05.